Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Lanar

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Vaccine|November 16, 2004
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malariaSpencer D Polley, Tabitha Mwangi, Clemens H M Kocken, et al.
Plos One|December 10, 2009
High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus modelSheetij Dutta, JoAnn S Sullivan, Katharine K Grady, et al.
The Journal of Infectious Diseases|May 17, 2003
The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort ProjectLauren M Singer, Lisa B Mirel, Feiko O ter Kuile, et al.
The Journal of Infectious Diseases|October 22, 2008
Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infantsRenée M Ned, April E Price, Sara B Crawford, et al.
NPJ Vaccines|December 22, 2017
Protein nanovaccine confers robust immunity against <i>Toxoplasma</i>Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2004
Update on the clinical development of candidate malaria vaccinesW Ripley Ballou, Myriam Arevalo-Herrera, Daniel Carucci, et al.
Infection and Immunity|March 5, 2008
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malariaFaith H A Osier, Gregory Fegan, Spencer D Polley, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2015
Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortArlene E Dent, Indu Malhotra, Xuelie Wang, et al.
Plos One|March 11, 2017
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccineMatthew B Laurens, Bourema Kouriba, Elke Bergmann-Leitner, et al.
Vaccine|April 19, 2016
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidateShawna F Graves, Bourema Kouriba, Issa Diarra, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Vaccine|November 16, 2004
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malariaSpencer D Polley, Tabitha Mwangi, Clemens H M Kocken, et al.
Plos One|December 10, 2009
High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus modelSheetij Dutta, JoAnn S Sullivan, Katharine K Grady, et al.
The Journal of Infectious Diseases|May 17, 2003
The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort ProjectLauren M Singer, Lisa B Mirel, Feiko O ter Kuile, et al.
The Journal of Infectious Diseases|October 22, 2008
Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infantsRenée M Ned, April E Price, Sara B Crawford, et al.
NPJ Vaccines|December 22, 2017
Protein nanovaccine confers robust immunity against <i>Toxoplasma</i>Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2004
Update on the clinical development of candidate malaria vaccinesW Ripley Ballou, Myriam Arevalo-Herrera, Daniel Carucci, et al.
Infection and Immunity|March 5, 2008
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malariaFaith H A Osier, Gregory Fegan, Spencer D Polley, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2015
Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortArlene E Dent, Indu Malhotra, Xuelie Wang, et al.
Plos One|March 11, 2017
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccineMatthew B Laurens, Bourema Kouriba, Elke Bergmann-Leitner, et al.
Vaccine|April 19, 2016
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidateShawna F Graves, Bourema Kouriba, Issa Diarra, et al.
Pageof 7